0001822479-22-000021.txt : 20220304
0001822479-22-000021.hdr.sgml : 20220304
20220304161355
ACCESSION NUMBER: 0001822479-22-000021
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220302
FILED AS OF DATE: 20220304
DATE AS OF CHANGE: 20220304
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Rutz Michael P
CENTRAL INDEX KEY: 0001599220
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39729
FILM NUMBER: 22714217
MAIL ADDRESS:
STREET 1: 8755 WEST HIGGINS ROAD
STREET 2: SUITE 500
CITY: CHICAGO
STATE: IL
ZIP: 60631
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Sotera Health Co
CENTRAL INDEX KEY: 0001822479
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090]
IRS NUMBER: 473531161
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9100 SOUTH HILLS BLVD, SUITE 300
CITY: BROADVIEW HEIGHTS
STATE: OH
ZIP: 44147
BUSINESS PHONE: 440-262-1410
MAIL ADDRESS:
STREET 1: 9100 SOUTH HILLS BLVD, SUITE 300
CITY: BROADVIEW HEIGHTS
STATE: OH
ZIP: 44147
FORMER COMPANY:
FORMER CONFORMED NAME: Sotera Health Topco, Inc.
DATE OF NAME CHANGE: 20200824
4
1
wf-form4_164642841992993.xml
FORM 4
X0306
4
2022-03-02
0
0001822479
Sotera Health Co
SHC
0001599220
Rutz Michael P
C/O SOTERA HEALTH COMPANY
9100 SOUTH HILLS BLVD, SUITE 300
BROADVIEW HEIGHTS
OH
44147
0
1
0
0
President of Sterigenics
Common Stock, $0.01 par value per share ("Common Stock")
2022-03-02
4
A
0
24962
0
A
577094
D
Stock Options
20.03
2022-03-02
4
A
0
63857
0
A
2032-03-02
Common Stock
63857.0
63857
D
Stock Options
23.0
2030-11-20
Common Stock
111801.0
111801
D
These securities consist of Restricted Stock Units ("RSUs") that were granted on March 2, 2022, pursuant to the terms of an RSU agreement under the Sotera Health Company 2020 Omnibus Incentive Plan ("2020 Incentive Plan"). Each RSU represents the Reporting Person's right to receive one share of common stock, subject to vesting conditions. The RSUs vest in three equal installments on each of the first three anniversaries of the date of grant, subject to the Reporting Person's continued service through each such date.
These securities consist of 44,526 RSUs and 532,568 shares of Common Stock. 162,480 of the shares of Common Stock are vested, and 370,088 shares of Common Stock remain subject to vesting conditions. Shares of unvested Common Stock will vest on a daily basis, pro rata through May 13, 2025 (the five year anniversary of the date of grant).
These options were granted on March 2, 2022, pursuant to the terms of a stock option agreement under the 2020 Incentive Plan. The options vest in three equal installments on each of the first three anniversaries of the date of grant, subject to the Reporting Person's continued service through each such date.
No transaction is being reported on this line. Reported on a previously filed Form 4.
These options were granted on November 20, 2020, pursuant to the terms of a stock option agreement under the 2020 Incentive Plan. 25% of the options vested on November 20, 2021 and the remaining unvested options vest in three equal installments on the next three anniversaries of the date of grant, subject to the Reporting Person's continued service through each such date.
The Power of Attorney for Mr. Rutz is filed as an exhibit to the Form 3 filed on November 20, 2020, which is hereby incorporated by reference.
/s/ Jessica L. M. H. Epp, Attorney-in-Fact
2022-03-04